Skip to content

April 2026

DMT

What April 2026's 9 new studies found, synthesized from the papers below. All DMT research →

The synthesis

Synthesized from 9 studies in the library · AI-generated, grounded in the abstracts below

Found by searching the library for DMT, dimethyltryptamine, 5-MeO-DMT, then ranked by relevance.

Research on DMT in April 2026 shows that DMT and related compounds (5-MeO-DMT, ayahuasca) have large effects on reducing substance misuse (g=0.94) and suicidal ideation in depression, but these findings come from studies with high risk of bias and heterogeneity. A reanalysis of EEG data found that DMT causes bidirectional collapse of alpha wave power rather than an increase in forward waves, challenging prior interpretations. The evidence is limited by small samples, open-label designs, and a lack of large-scale controlled trials.

Confidence in the evidence

Low-Moderate
  • One meta-analysis (article 27274) shows large effect sizes but with high heterogeneity (I²=96.9%) and high risk of bias across studies.
  • A systematic review (article 28190) on ayahuasca for suicidal ideation includes only 5 studies with methodological heterogeneity.
  • The EEG reanalysis (article 28222) has a small sample (N=12) and reanalyzes existing data, limiting generalizability.
  • Several studies are protocols or theoretical proposals (articles 28217, 28219, 28224) with no empirical results yet.
  • No large-scale RCTs on DMT for any condition were reported in this set.
How we rate confidence

Confidence reflects the strength of the underlying evidence, not whether the result is favorable. It weighs the number and size of studies, their design (randomized trials count for more than observational or single-case work), how consistently they point the same way, and their risk of bias.

Tiers run from Insufficient to High. High is rare in this field: small, early, or open-label studies land lower even when their direction is encouraging.

Evidence by study

Direction is each study's finding relative to your question: Supports, Opposes, No effect, Mixed, or Unclear.

Low-dose 5-MeO-DMT combined with council practice may support transformative leadership by deepening empathy and collective intelligence.

theoretical/qualitative

This protocol describes a dyadic DMTx stimulation test for anomalous information transfer between isolated participants, but no results are reported.

protocol

Informal and underground use of 5-MeO-DMT over 25 years has generated substantial anecdotal evidence for alleviating depressive symptoms, but formal clinical development is lacking.

review/opinion

Ayahuasca administration is consistently associated with rapid and significant reductions in suicidal ideation and depressive symptoms, attributed to neuroplasticity and DMN modulation.

systematic review Sample size: 5

This protocol proposes to investigate expanded states of consciousness induced by ayahuasca and DMT using EEG gamma oscillations and a brain-machine interface, but no results are reported.

protocol/theoretical

This protocol proposes testing whether the radical pair mechanism operates during DMT-induced states via isotopic substitution, but no results are reported.

protocol

DMT yielded a large overall effect size for substance abuse reduction (g=0.94), with greater effects when combined with psychotherapy (g=1.38) and for drug use (g=1.35) versus alcohol (g=0.65).

systematic review and meta-analysis

DMT causes bidirectional collapse of alpha wave power rather than an increase in forward travelling waves, contradicting prior findings; absolute forward power decreased in all 12 subjects.

reanalysis of EEG data Sample size: 12

This paper formalizes endogenous DMT as a key component in a mathematical framework of consciousness, predicting specific EEG effects and testable consequences, but no empirical data are presented.

theoretical

Points of agreement

  • DMT and related compounds show potential therapeutic effects for psychiatric conditions (depression, substance misuse, suicidal ideation).
  • Therapeutic effects are often attributed to neuroplasticity and modulation of brain networks like the Default Mode Network.
  • There is a recognized gap between informal/underground knowledge and formal clinical research.

Conflicts

  • The EEG reanalysis (article 28222) contradicts earlier findings (Alamia et al., 2020) on the direction of cortical travelling waves under DMT.
  • The meta-analysis (article 27274) shows high heterogeneity, indicating inconsistent effects across studies.

Gaps

  • No large-scale, double-blind, placebo-controlled RCTs on DMT for any condition are reported in this set.
  • Durability of therapeutic effects beyond short-term follow-up is not established.
  • Most studies are protocols, theoretical papers, or reanalyses with small samples.
  • Specific mechanisms (e.g., radical pair, theta field) remain untested empirically.
  • Safety and long-term outcomes in clinical populations are not addressed.
Browse these studies in the library